跳至主要内容
临床试验/NCT04580940
NCT04580940已完成不适用

Flexible Percutaneous Transhepatic Cholangiopancreatoscopy (PTCS) in Complex Pancreaticobiliary Disease

Boston Scientific Corporation7 个研究点 分布在 7 个国家目标入组 50 人开始时间: 2021年7月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
7
主要终点
Achieving clinical intent of procedure as indicated

研究概览

简要总结

To document the clinical utility of percutaneous cholangiopancreatoscopy using a thin, disposable, flexible endoscope for evaluation and treatment of complex pancreaticobiliary disease in a prospective, multi-center case series

详细描述

This case series aims to illustrate the clinical utility of percutaneous transhepatic cholangiopancreatoscopy using a thin, disposable, flexible endoscope performed by gastroenterological endoscopists and/or interventional radiologists in procedures including but not limited to:

  • PTCS for tissue diagnosis in cases of surgically or pathologically-altered anatomy,
  • PTCS for stone removal after surgically or pathologically-altered anatomy,
  • Percutaneous rendezvous to aid ERCP after failed endoscopic cannulation,
  • Percutaneous delivery of palliative intraluminal brachytherapy,
  • Intra-procedural percutaneous salvage procedures when an initial route of access fails

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for a percutaneous transhepatic procedure to access the pancreaticobiliary anatomy that will accommodate passage of SpyGlass™ Discover Digital Catheter per local standard of practice
  • Written informed consent from patient or legally authorized representative of the patient

排除标准

  • Contraindication for cholangiopancreatoscopy
  • Subjects with unresolved adverse event(s) associated with prior percutaneous pancreaticobiliary ductal access
  • <18 years of age
  • Potentially vulnerable subjects, including, but not limited to pregnant women

结局指标

主要结局

Achieving clinical intent of procedure as indicated

时间窗: 1 month

Physicians will report achieving clinical success by recording the completed procedures compared to procedures planned by 30 days (+/- 3 days) after index PTCS.

次要结局

  • Number of Adverse Events(1 month)
  • Technical success(During index procedure)
  • Procedural Time(During index procedure)
  • Endoscopist rating(During index procedure)
  • Number of PTCS procedures(1 month)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验